Want to track 1477 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ocumension Therapeutics (1477) Statistics
Valuation metrics
Market Cap 4.33B
Enterprise value 3.47B
Trailing P/E (ttm) -22.35
Forward P/E -
PEG ratio -0.37
Price/Sales (ttm) 4.54
Price/Book (mrq) 0.98
Enterprise Value/Revenue 4.31
Enterprise Value/EBITDA -115.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 386.54K
Average volume (90 days) 1.25M
Price summary
52-Week low 4.04
52-Week high 12.23
Beta -
50-Day moving average 5.16
200-Day moving average 6.47
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.2%
Operating margin -0.2%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 3.7%
Book value per share (mrq) 4.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
